Lantus Solostar

Lantus Solostar

insulin glargine




Concise Prescribing Info
Insulin glargine
DM in adult, adolescents & childn ≥2 yr.
Dosage/Direction for Use
Administer SC once daily at the same time everyday. Dose & timing of dose should be individually adjusted.
Special Precautions
Hypothyroidism. Transfer from other types of insulin. Inadequate dosing or discontinuation of treatment. Illness or major injury; not eating enough. Insulin treatment may produce Ab to insulin (very rarely). Heart failure in patients w/ long-standing type 2 DM & heart disease or previous stroke treated w/ pioglitazone & insulin. Monitor blood sugar frequently. Switch from 1 insulin therapy to another require medical prescription, medical supervision & blood glucose monitoring. For SC use only. Renal or hepatic impairment. May impair ability to drive or operate machinery. Pregnancy & lactation. Childn <2 yr.
Adverse Reactions
Hypoglycemia; severe allergic reactions. Lipoatrophy, lipohypertrophy; skin & allergic reactions at inj site eg, reddening, unusually intense inj pain, itching, hives, swelling or inflammation.
Drug Interactions
May cause hyperglycemia w/ all other medicines to treat diabetes, ACE inhibitors, disopyramide, fluoxetine, fibrates, MAOIs, pentoxifylline, propoxyphene, salicylates, sulfonamides. May cause hyperglycemia w/ corticosteroids, danazol, diazoxide, diuretics, glucagon, INH, oestrogens & progestogens, phenothiazine derivatives, somatropin, sympathomimetics (eg, epinephrine, salbutamol, terbutaline), thyroid hormones, atypical antipsychotics (eg, clozapine, olanzapine), PIs. Enhanced/reduced effects w/ β-blockers, clonidine, lithium salts & alcohol. Pentamidine may cause hypoglycemia, sometimes followed by hyperglycemia. May weaken or suppress entirely the 1st warning symptoms of hypoglycemia w/ β-blocker, clonidine, guanethidine & reserpine.
MIMS Class
Insulin Preparations
ATC Classification
A10AE04 - insulin glargine ; Belongs to the class of long-acting insulins and analogues for injection. Used in the treatment of diabetes.
Lantus Solostar soln for inj 3.64 mg/mL (100 u/mL)
3 mL x 5 × 1's (P4,294/pre-filled pen)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in